Developer of disease modifying therapies intended to improve survival, quality of life and outcomes for patients with lung cancer, COPD, asthma and other pulmonary diseases. The company's therapies address the needs of interventional pulmonologists, thoracic surgeons and all physicians who treat pulmonary disease, enabling physicians to treat their patients better, resulting in a better medical outcome.